# Cluster4-11 Analysis

## Proteins: 

ABHD10, BBS4, CAMK2B, CAMK2D, ELP1, ELP2, ELP3, FAM43B, GSK3A, IMPDH1, IMPDH2, KCTD12, KLHDC8B, MARK4, MYO9B, PUSL1, PYCR3, RAPGEF6, SAPCD2, SHC1, ST6GALNAC5, TTC31, UNG, ZNRD2

### Cytosolic Protein Interaction and Regulation System

**Summary**

The human protein system analyzed here consists of 24 proteins, with a majority of them localized in the cytosol (17 proteins) and involved in protein binding (16 proteins). The proteins are involved in various cellular processes, including protein phosphorylation, transcription, translation, and signal transduction. Based on the cellular location and function, we propose the name "Cytosolic Protein Interaction and Regulation System" for this system.

The proteins in this system are involved in several cellular components and complexes, such as the elongator holoenzyme complex, calcium- and calmodulin-dependent protein kinase complex, and ciliary basal body. They participate in biological processes like protein phosphorylation, transcription by RNA polymerase II, translation, and tRNA wobble uridine modification. Some proteins also play roles in nervous system development, neuron projection, and cell division.

**References**

1. Huttlin, E. L., Bruckner, R. J., Paulo, J. A., Cannon, J. R., Ting, L., Baltier, K., Colby, G., Gebreab, F., Gygi, M. P., Parzen, H., Szpyt, J., Tam, S., Zarraga, G., Pontano-Vaites, L., Swarup, S., White, A. E., Schweppe, D. K., Rad, R., Erickson, B. K., Obar, R. A., Guruharsha, K. G., Li, K., Artavanis-Tsakonas, S., Gygi, S. P., & Harper, J. W. (2017). Architecture of the human interactome defines protein communities and disease networks. Nature, 545(7655), 505-509.

2. Szklarczyk, D., Gable, A. L., Lyon, D., Junge, A., Wyder, S., Huerta-Cepas, J., Simonovic, M., Doncheva, N. T., Morris, J. H., Bork, P., Jensen, L. J., & von Mering, C. (2019). STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Research, 47(D1), D607-D613.

3. Ashburner, M., Ball, C. A., Blake, J. A., Botstein, D., Butler, H., Cherry, J. M., Davis, A. P., Dolinski, K., Dwight, S. S., Eppig, J. T., Harris, M. A., Hill, D. P., Issel-Tarver, L., Kasarskis, A., Lewis, S., Matese, J. C., Richardson, J. E., Ringwald, M., Rubin, G. M., & Sherlock, G. (2000). Gene ontology: tool for the unification of biology. Nature Genetics, 25(1), 25-29.

## Gene Feature Summary: 

| Feature | Number of Genes | Genes |
| --- | --- | --- |
| cytosol | 17 | BBS4, MARK4, GSK3A, MYO9B, ELP1, CAMK2D, IMPDH1, RAPGEF6, SAPCD2, ABHD10, CAMK2B, ELP2, SHC1, IMPDH2, KLHDC8B, PYCR3, ELP3 |
| protein binding | 16 | UNG, KCTD12, BBS4, MARK4, GSK3A, MYO9B, ELP1, CAMK2D, RAPGEF6, SAPCD2, ZNRD2, CAMK2B, SHC1, IMPDH2, PYCR3, ELP3 |
| cytoplasm | 11 | MARK4, GSK3A, MYO9B, ELP1, CAMK2D, IMPDH1, CAMK2B, ELP2, IMPDH2, KLHDC8B, ELP3 |
| nucleus | 8 | UNG, BBS4, GSK3A, ELP1, CAMK2D, IMPDH1, IMPDH2, ELP3 |
| nucleoplasm | 5 | UNG, CAMK2D, SAPCD2, CAMK2B, ELP2 |
| ATP binding | 5 | MARK4, GSK3A, MYO9B, CAMK2D, CAMK2B |
| mitochondrion | 4 | UNG, GSK3A, ABHD10, PUSL1 |
| RNA binding | 4 | KCTD12, IMPDH1, IMPDH2, PUSL1 |
| identical protein binding | 4 | KCTD12, CAMK2D, CAMK2B, IMPDH2 |
| protein serine kinase activity | 4 | MARK4, GSK3A, CAMK2D, CAMK2B |
| protein phosphorylation | 4 | MARK4, GSK3A, CAMK2D, CAMK2B |
|  transcription by RNA polymerase II | 4 | GSK3A, CAMK2D, ELP2, ELP3 |
| centrosome | 3 | BBS4, MARK4, RAPGEF6 |
| protein serine/threonine kinase activity | 3 | MARK4, GSK3A, CAMK2D |
| nervous system development | 3 | MARK4, GSK3A, CAMK2B |
| neuron projection | 3 | MARK4, CAMK2D, CAMK2B |
| peptidyl-serine phosphorylation | 3 | GSK3A, CAMK2D, CAMK2B |
| calmodulin binding | 3 | MYO9B, CAMK2D, CAMK2B |
| protein homodimerization activity | 3 | MYO9B, CAMK2D, CAMK2B |
| membrane | 3 | MYO9B, CAMK2D, IMPDH2 |
| tRNA wobble uridine modification | 3 | ELP1, ELP2, ELP3 |
|  translation | 3 | ELP1, ELP2, ELP3 |
| elongator holoenzyme complex | 3 | ELP1, ELP2, ELP3 |
| metal ion binding | 3 | IMPDH1, IMPDH2, ELP3 |
| negative regulation of apoptotic process | 2 | UNG, SHC1 |
| microtubule cytoskeleton organization | 2 | BBS4, MARK4 |
| neuron migration | 2 | BBS4, ELP3 |
|  cilium assembly | 2 | BBS4, MARK4 |
| ciliary basal body | 2 | BBS4, MARK4 |
| tau protein binding | 2 | MARK4, GSK3A |
| tau-protein kinase activity | 2 | MARK4, GSK3A |
| intracellular signal transduction | 2 | MARK4, SHC1 |
| cell division | 2 | MARK4, ZNRD2 |
| microtubule organizing center | 2 | MARK4, CAMK2B |
| midbody | 2 | MARK4, KLHDC8B |
| insulin receptor signaling pathway | 2 | GSK3A, SHC1 |
|  neuron projection development | 2 | GSK3A, CAMK2B |
| peptidyl-threonine phosphorylation | 2 | GSK3A, CAMK2D |
|  heart contraction | 2 | GSK3A, CAMK2D |
| actin binding | 2 | MYO9B, CAMK2B |
| small GTPase binding | 2 | MYO9B, RAPGEF6 |
| tRNA binding | 2 | ELP1, ELP3 |
| tRNA wobble base 5-methoxycarbonylmethyl-2-thiouridinylation | 2 | ELP1, ELP3 |
| calmodulin-dependent protein kinase activity | 2 | CAMK2D, CAMK2B |
| protein autophosphorylation | 2 | CAMK2D, CAMK2B |
| calcium- and calmodulin-dependent protein kinase complex | 2 | CAMK2D, CAMK2B |
| endocytic vesicle membrane | 2 | CAMK2D, CAMK2B |
| sarcoplasmic reticulum membrane | 2 | CAMK2D, CAMK2B |
| nucleotide binding | 2 | IMPDH1, IMPDH2 |
| DNA binding | 2 | IMPDH1, IMPDH2 |
| IMP dehydrogenase activity | 2 | IMPDH1, IMPDH2 |
| GMP biosynthetic process | 2 | IMPDH1, IMPDH2 |
| GTP biosynthetic process | 2 | IMPDH1, IMPDH2 |
| extracellular region | 2 | IMPDH1, IMPDH2 |
| secretory granule lumen | 2 | IMPDH1, IMPDH2 |
| ficolin-1-rich granule lumen | 2 | IMPDH1, IMPDH2 |
| plasma membrane | 2 | RAPGEF6, SHC1 |
| apical plasma membrane | 2 | RAPGEF6, SAPCD2 |
|  cell population proliferation | 2 | SAPCD2, SHC1 |
| nucleolus | 2 | SAPCD2, ELP3 |
| mitochondrial matrix | 2 | ABHD10, SHC1 |
| intercellular bridge | 2 | KLHDC8B, PYCR3 |

